The report "Dengue Vaccine Market by Product Type (CYD-TDV (Dengvaxia), DENVax, TetraVax-DV, Others), by Vaccine Type (Live Attenuated Vaccine, Killed Vaccine, Others), By End User (Hospitals, Clinics, Government Institutes, Non-Governmental Organizations (NGOs)) - Global Forecasts to 2030", is projected to reach USD 472.6 million in 2023, registering at a Compound Annual Growth Rate (CAGR) of 12.8% during the forecast period 2024-2030. The growth of the dengue vaccine market is majorly driven by the growing incidence of dengue and growing research and development activities.
Request Sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=15690
The dengue virus is the cause of dengue, a tropical illness spread by mosquitoes. Usually starting three to fourteen days after infection, this illness presents symptoms. Vomiting, a high temperature, headaches, joint and muscle aches, and a distinctive skin rash are among the symptoms. Only those who have a verified history of dengue virus infection should receive the vaccination, according to recommendations made by the World Health Organisation (WHO).
Competitive Dashboard:
The prominent key players operating in the global dengue vaccine market are Biological E Ltd., GlaxoSmithKline Plc., GeneOne Life Science Inc., Sanofi Pasteur Limited, Takeda Pharmaceutical Company Limited, Merck Co. Inc., Medigen Vaccine Biologics Corporation, Panacea Biotec Limited, Sun Pharmaceutical Industries Ltd, Serum Institute of India Pvt. Ltd.
Regional Overview:
The report also examines the current concerns and their Future Effects on the dengue vaccine market by the region. The report covers all regions and countries, North America was the largest and Asia was the fastest-growing region in the Dengue Vaccine Market. The market has been segmented into numerous primary regions and a detailed evaluation of primary countries.
- North America (U.S., Canada)
- Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
- Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
- Middle East Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)
A Few Points from the Table of Contents –
1. Executive Summary
2. Global Dengue Vaccine Market Introduction
3. Global Dengue Vaccine Market Dynamics
4. Global Dengue Vaccine Market Analysis, 2019 - 2023 and Forecast 2024 – 2030
……………….
9. Global Dengue Vaccine Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10. North America Dengue Vaccine Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11. Europe Dengue Vaccine Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12. Asia Pacific (APAC) Dengue Vaccine Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13. Middle East and Africa (MEA) Dengue Vaccine Market 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
14. Latin America Dengue Vaccine Market 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
15. Competition Landscape
16. Research Methodology
17. Appendix and Abbreviations
Scope of The Report:
- The dengue vaccine market research report includes historical data, trending features, and market growth estimates for the future.
- The dengue vaccine market qualitative and quantitative analysis of the market along with CAGR calculation for the forecast period.
- The market report helps to provide the best results for business enhancement and business growth.
- The dengue vaccine market report gives a comprehensive overview of both primary and secondary data.
- The dengue vaccine market key players covered here to help them strengthen their place in the market.
About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to delivering more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.
Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.
Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747
